Strella Biotechnology
Latest round
- Series A
Last raised
- Jun 2022
Total raised
- $11M
Investors
- 7
About Strella Biotechnology
Strella Biotechnology, Inc.Founded in 2017 and headquartered in Seattle, US, Strella Biotechnology develops innovative monitoring technology for the agricultural sector. The company was co-founded by Jay Jordan and Katherine Sizov, who have previously been involved in launching and managing other ventures.Strella Biotechnology specializes in advanced monitoring solutions for the produce supply chain, focusing on optimizing storage, ripening, sequencing, and environmental monitoring of fruits and vegetables. Their core product offerings include high-tech sensors that measure ethylene levels, a key gas affecting the ripening process, thereby helping growers and shippers manage the maturity of their produce more effectively. These solutions are designed to reduce waste and enhance the quality of produce as it transitions from the field to consumers. Strella serves various clients within the agricultural sector, including growers, distributors, and retailers, and is actively engaged in markets across the United States.Strella Biotechnology generates revenue primarily through subscription-based partnerships with agricultural producers, distributors, and retailers. This model allows clients to access the company's proprietary technology and services, which are instrumental in minimizing waste and optimizing the quality of produce throughout the supply chain. Transactions typically involve long-term contracts that grant access to Strella's monitoring systems and data analytics capabilities. The company’s flagship products, including real-time environmental monitoring systems and ethylene sensors, align with their goal to enhance operational efficiency in the produce sector. The company is targeting growth into new markets across the United States, with specific strategies focused on enhancing its technology offerings to meet evolving agricultural needs. Further product introductions are anticipated as part of their ongoing commitment to innovation in the produce supply chain.
Who invested in Strella Biotechnology
7 investors across 2 rounds
See all investors in Strella Biotechnology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Strella Biotechnology
Who invested in Strella Biotechnology?
Strella Biotechnology has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Strella Biotechnology raised?
Strella Biotechnology has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Strella Biotechnology last raise money?
Strella Biotechnology's most recent round on record is a Series A, in Jun 2022.
What does Strella Biotechnology do?
Strella Biotechnology is a biotechnology company.
Where is Strella Biotechnology headquartered?
Strella Biotechnology is headquartered in Seattle, US.
Which VCs invest in companies like Strella Biotechnology?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Strella Biotechnology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Strella Biotechnology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.